Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Key Inclusion Criteria:~* Patient has discrete de novo lesion of a coronary artery with symptomatic ischemic heart disease~* Planned treatment of one lesion with a single stent~* Denovo type A, B1 lesions with a Reference diameter between 3.0 and 3.5mm and a lesion length between 5 and 16mm~Key Exclusion Criteria:~* Diabetic (HbA1C \>6.0)~* Platelet count \< 100000 cells/mm3 or \> 700000 cells/mm3; WBC \< 3000 cells/mm3; or a hemoglobin \< 10 g/dl~* Renal dysfunction with creatinine \> 2.0 mg/dl~* Patient has a known pre-dilatation ejection fraction (EF) less than forty five (\<45%)~* Myocardial infarction (MI) less than 3 months prior to intervention~* Patient has type B2, C lesion~* Reference artery diameter \<3.0 or \>3.6 mm~* Target lesion length \< 5mm and \>16 mm~* Other stenosis \>50% in target vessel~* Known hypersensitivity or contraindication to aspirin, clopidogrel, ticlopidine, or cobalt chromium, or a sensitivity to contrast agent that, in the opinion of the investigator, cannot be adequately premedicated.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Device

Based on this trial design, predict the completion outcome and termination type (if applicable).